Advertisement
Journal Home
Search for

Articles in Press

Return to articles in press list

Hypolipidemic effect of the polysaccharide from Pholiota nameko

Haiping Li, Ph.D.Corresponding Author Informationemail address, Mingming Zhang, B.S., Guiji Ma, B.S.

Received 26 May 2009; accepted 1 June 2009. published online 08 October 2009.
Corrected Proof

Abstract 

Objective

This study was conducted to investigate the hypolipidemic effect of the polysaccharide isolated from Pholiota nameko (PNPS-1).

Methods

Hyperlipidemic Wistar rats were treated with PNPS-1 (20, 40, and 60mg/kg orally).

Results

Treatment of hyperlipidemic Wistar rats with PNPS-1 led not only to significant decreases in very low-density lipoprotein/low-density lipoprotein cholesterol (−48.98% and −21.54%, 40 and 60mg/kg), triacylglycerol (−19.70%, −17.17%, −32.32%), phospholipids (−9.90%, −19.80%, −27.08%), and consequently the atherogenic index (23.61%, 70.42%, 82.85%) and a increase in high-density lipoprotein cholesterol (69.01% and 73.35%, 40 and 60mg/kg) in serum, but also to significant decreases in total lipids (−10.24% and −33.16%, 40 and 60mg/kg), total cholesterol (−24.22%, −34.26%, −55.02%), triacylglycerol (−22.53% and −38.50%, 40 and 60mg/kg), and phospholipids (−27.41%, 60mg/kg) in the liver. Further, PNPS-1 significantly suppressed lipid peroxidation by decreasing malondialdehyde and increasing antioxidant enzymes in serum (malondialdehyde, 9.94%, −22.22%, −32.75%; superoxide dismutase, 37.26%, 101%, 114%; catalase, 32.2%, 30.02%, 36.74%; glutathione peroxidase, 31.30%, 35.56%, 52.34%) of the 20-, 40-, and 60-mg/kg PNPS-1 groups and in the liver (malondialdehyde, −32.26%, −47.85%; catalase, 97%, 117%; glutathione peroxidase, 70.70%, 78.03%) in the 40- and 60-mg/kg PNPS-1 groups (superoxide dismutase, 24.35%, 67.49%, 234%). PNPS-1 was also effective in lowering body weight and some visceral weights (liver, heart, and kidney) in treated rats, except for the lung. PNPS-1 also ameliorated the pathologic changes in coronary arteries of hyperlipidemic rats.

Conclusion

These results suggested that PNPS-1 significantly suppresses the development of hyperlipidemia and might be used as a potential therapeutic agent for hyperlipidemia.

Tianjin Key Laboratory of Food Biotechnology, Faculty of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin, Peoples Republic of China

Corresponding Author InformationTo whom correspondence should be addressed. Tel: 86-22-81720649; fax: 86-22-26669795

PII: S0899-9007(09)00248-2

doi:10.1016/j.nut.2009.06.009

Advertisement